Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pain × Standard of Care × Clear all

Phase

Status

Withdrawn 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms by Site 2 Motor Activity 2 Head and Neck Neoplasms 2 Glioma 2 Carcinoma, Transitional Cell 2 Anxiety Disorders 2 Uterine Neoplasms 1 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Pain 1

Interventions

Morphine 5 Methadone 4 Fentanyl 4 Zoledronic Acid 3 Tapentadol 2 Radiotherapy 2 Pregabalin 2 Prednisone 2 Ketamine 2 Ibandronic Acid 2 Hydromorphone 2 Glutamine 2 Acupuncture Therapy 2 pegfilgrastim 1 oxycodone naloxone combination 1 naloxegol 1 ixabepilone 1 incobotulinumtoxinA 1 imisopasem manganese 1 cyclobenzaprine 1 cabozantinib 1 acetaminophen, aspirin, caffeine drug combination 1 Zolpidem 1 Surveys and Questionnaires 1 Sugars 1 Standard of Care 1 Soybean Proteins 1 Sodium Bicarbonate 1 Ropivacaine 1 Oxycodone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02867644 2022-12-20

HYCOREMA

Institut de Cancérologie de Lorraine

Phase NA Terminated

Anxiety Disorders, Breast Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡